6/7/2010

Some U.S. patients with cerebral palsy and other diseases are undergoing experimental stem cell treatments in China, a trend that Western scientists say could jeopardize the health of patients. Moreover, the stem cells used in most clinics in the country are derived from miscarried fetuses, a practice that raises ethical and religious concerns.

Related Summaries